Aortic Stenosis and Heart Failure with Preserved Ejection Fraction: A Shared Phenotypic Puzzle
Authors:
- 24 October 2023
- journal article
- editorial
- Published by Oxford University Press (OUP) in European Journal of Heart Failure
- Vol. 25 (11) , 1959-1961
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and ObesityNew England Journal of Medicine, 2023
- Haemodynamic and Metabolic Phenotyping of Patients with Aortic Stenosis and Preserved Ejection Fraction: A Specific Phenotype of Heart Failure with Preserved Ejection Fraction?European Journal of Heart Failure, 2023
- Quantitative Fluid Overload in Severe Aortic Stenosis Refines Cardiac Damage and Associates with Worse OutcomesEuropean Journal of Heart Failure, 2023
- Association of epicardial adipose tissue with proteomics, coronary flow reserve, cardiac structure and function, and quality of life in heart failure with preserved ejection fraction: insights from the PROMIS‐HFpEF studyEuropean Journal of Heart Failure, 2022
- Impact of Moderate Aortic Stenosis on Long-Term Clinical OutcomesJACC: Cardiovascular Interventions, 2022
- Evolution and Prognostic Impact of Cardiac Damage After Aortic Valve ReplacementJACC, 2022
- Impact of epicardial adipose tissue on cardiovascular haemodynamics, metabolic profile, and prognosis in heart failureEuropean Journal of Heart Failure, 2021
- Effects of Semaglutide Versus Dulaglutide on Epicardial Fat Thickness in Subjects with Type 2 Diabetes and ObesityJournal of the Endocrine Society, 2020
- Prognostic Implications of Congestion on Physical Examination Among Contemporary Patients With Heart Failure and Reduced Ejection FractionCirculation, 2019
- Epicardial Adipose Tissue and Myocardial Fibrosis in Aortic Stenosis Relationship With Symptoms and OutcomesJACC: Cardiovascular Imaging, 2019